Literature DB >> 9574695

Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics.

C A Gaydos1, M R Howell, T C Quinn, J C Gaydos, K T McKee.   

Abstract

Ligase chain reaction (LCR) (Abbott Laboratories, Abbott Park, Ill.) with first-catch urine specimens was used to detect Chlamydia trachomatis infections in 465 asymptomatic military women attending clinics for routine Papanicolaou smear tests. Results were compared to results of cervical culture to determine the sensitivity of the urine LCR and the possible presence of inhibitors of amplification in pregnant and nonpregnant women. Discrepant results for LCR and culture were resolved by direct fluorescent antibody staining of culture sediments, two different PCR assays, and LCR for the outer membrane protein 1 gene. The prevalence of Chlamydia in specimens by urine LCR was 7.3% compared to 5% by culture. For 434 women with matching specimens, there were 11 more specimens positive by LCR than were positive by culture, of which all but one were determined to be true positives. There were four culture-positive, LCR-negative specimens, all from nonpregnant women. The sensitivity, specificity, and positive and negative predictive values of urine LCR after discrepant results were resolved were 88.6, 99.7, 96.9, and 99.0%, respectively. The sensitivity of culture was 71.4%. From the 148 pregnant women (prevalence by LCR, 6.8%), there were no patients who were cervical culture positive and urine LCR negative to indicate the presence in pregnant women of inhibitors of LCR. Additionally, a subset of 55 of the LCR-negative frozen urine specimens from pregnant women that had been previously processed in LCR buffer were inoculated with 5 cell culture inclusion forming units of C. trachomatis each and retested by LCR; all tested positive, indicating the absence of inhibitors of LCR in urine from these pregnant women. The use of LCR testing of urine specimens from asymptomatic women, whether pregnant or not, offers a sensitive and easy method to detect C. trachomatis infection in women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574695      PMCID: PMC104818          DOI: 10.1128/JCM.36.5.1300-1304.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Sexually transmitted disease control in the armed forces, past and present.

Authors:  L A Emerson
Journal:  Mil Med       Date:  1997-02       Impact factor: 1.437

2.  Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis.

Authors:  I P Jensen; P Thorsen; B R Møller
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

3.  Urine as a diagnostic specimen for the detection of Chlamydia trachomatis in Malaysia by ligase chain reaction.

Authors:  C A Gaydos; Y F Ngeow; H H Lee; M Canavaggio; L E Welsh; J Johanson; T C Quinn
Journal:  Sex Transm Dis       Date:  1996 Sep-Oct       Impact factor: 2.830

4.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening.

Authors:  M Buimer; G J van Doornum; S Ching; P G Peerbooms; P K Plier; D Ram; H H Lee
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

5.  Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone?

Authors:  D J Mosure; S Berman; D Fine; S DeLisle; W Cates; J R Boring
Journal:  J Adolesc Health       Date:  1997-01       Impact factor: 5.012

6.  Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis.

Authors:  D J Mosure; S Berman; D Kleinbaum; M E Halloran
Journal:  Am J Epidemiol       Date:  1996-11-15       Impact factor: 4.897

7.  Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships.

Authors:  T C Quinn; C Gaydos; M Shepherd; L Bobo; E W Hook; R Viscidi; A Rompalo
Journal:  JAMA       Date:  1996-12-04       Impact factor: 56.272

8.  Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay.

Authors:  R P Verkooyen; A Luijendijk; W M Huisman; W H Goessens; J A Kluytmans; J H van Rijsoort-Vos; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction.

Authors:  G J van Doornum; M Buimer; M Prins; C J Henquet; R A Coutinho; P K Plier; S Tomazic-Allen; H Hu; H Lee
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-08-06
View more
  13 in total

1.  Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis Infections.

Authors:  Deborah J Jespersen; Karen S Flatten; Mary F Jones; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR.

Authors:  Charlotte A Gaydos; Kimberly A Crotchfelt; Nina Shah; Marie Tennant; Thomas C Quinn; Joel C Gaydos; Kelly T McKee; Anne M Rompalo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Prenatal and Infancy Nurse Home Visiting and 18-Year Outcomes of a Randomized Trial.

Authors:  Harriet Kitzman; David L Olds; Michael D Knudtson; Robert Cole; Elizabeth Anson; Joyce A Smith; Diana Fishbein; Ralph DiClemente; Gina Wingood; Angela M Caliendo; Christian Hopfer; Ted Miller; Gabriella Conti
Journal:  Pediatrics       Date:  2019-11-20       Impact factor: 7.124

4.  Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.

Authors:  T L Lauderdale; L Landers; I Thorneycroft; K Chapin
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases.

Authors:  Charlotte A. Gaydos; Anne M. Rompalo
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

6.  Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.

Authors:  L F Lawing; S R Hedges; J R Schwebke
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.

Authors:  S A Morré; I G Van Valkengoed; R M Moes; A J Boeke; C J Meijer; A J Van den Brule
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Geographic epidemiology of gonorrhoea and chlamydia on a large military installation: application of a GIS system.

Authors:  J M Zenilman; G Glass; T Shields; P R Jenkins; J C Gaydos; K T McKee
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

9.  LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value.

Authors:  J M Zenilman; W C Miller; C Gaydos; S M Rogers; C F Turner
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

10.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.